Conflicts of interest P.C., A.R. and G.B. are employees of Wyeth Pharmaceuticals, the manufacturer of Enbrel® (etanercept).
Economic evaluation of etanercept in the management of chronic plaque psoriasis
Article first published online: 19 SEP 2008
© 2008 The Authors. Journal Compilation © 2008 British Association of Dermatologists
British Journal of Dermatology
Volume 160, Issue 2, pages 380–386, February 2009
How to Cite
Lloyd, A., Reeves, P., Conway, P., Reynolds, A. and Baxter, G. (2009), Economic evaluation of etanercept in the management of chronic plaque psoriasis. British Journal of Dermatology, 160: 380–386. doi: 10.1111/j.1365-2133.2008.08863.x
- Issue published online: 16 JAN 2009
- Article first published online: 19 SEP 2008
- Accepted for publication 22 June 2008
Options for accessing this content:
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!